GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
H

Hubei Fuxing Science and Technology Co 000926.SZ · CNY

Real Estate · Shenzhen · 🇨🇳 China

Compare

1.69

-0.59%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CNY, from our data supplier.

FY2025

Revenue

CN¥3.83bn

FY2016FY2025

Net income

−CN¥4.13bn

FY2016FY2025

Free cash flow

CN¥1.34bn

FY2016FY2025

Shareholders' equity

CN¥5.37bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueCN¥3.83bnCN¥8.76bnCN¥5.51bnCN¥15.14bnCN¥12.54bnCN¥7.50bnCN¥9.57bnCN¥10.74bnCN¥11.66bnCN¥10.48bn
Gross profitCN¥519.7mCN¥133.3mCN¥1.37bnCN¥2.76bnCN¥2.19bnCN¥1.55bnCN¥2.35bnCN¥3.27bnCN¥3.09bnCN¥2.36bn
Research and developmentCN¥27.8mCN¥34.1mCN¥35.3mCN¥34.6mCN¥52.1mCN¥38.5mCN¥48.2mCN¥47.3mCN¥43.7mCN¥32.9m
Operating incomeCN¥32.7m−CN¥2.22bnCN¥311.4mCN¥640.6mCN¥670.6mCN¥604.5mCN¥1.06bnCN¥2.05bnCN¥1.77bnCN¥1.22bn
Net income−CN¥4.13bn−CN¥2.60bnCN¥68.3mCN¥105.1mCN¥170.8mCN¥306.4mCN¥597.6mCN¥1.13bnCN¥845.4mCN¥581.1m
Diluted earnings per share-2.59-1.680.050.080.130.220.450.810.640.44

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsCN¥22.32bnCN¥28.11bnCN¥36.91bnCN¥38.28bnCN¥48.55bnCN¥52.45bnCN¥51.08bnCN¥47.48bnCN¥49.00bnCN¥45.54bn
Cash and short-term investments—CN¥1.15bnCN¥2.26bnCN¥2.74bnCN¥4.72bnCN¥4.79bnCN¥5.71bnCN¥3.53bnCN¥9.06bnCN¥10.18bn
Total liabilitiesCN¥16.11bnCN¥17.79bnCN¥23.85bnCN¥25.91bnCN¥36.13bnCN¥40.17bnCN¥38.71bnCN¥35.40bnCN¥37.11bnCN¥33.49bn
DebtCN¥2.15bnCN¥3.46bnCN¥6.56bnCN¥7.40bnCN¥11.37bnCN¥13.45bnCN¥14.94bnCN¥18.47bnCN¥22.81bnCN¥18.95bn
Shareholders' equityCN¥5.37bnCN¥9.43bnCN¥12.09bnCN¥11.26bnCN¥11.20bnCN¥11.09bnCN¥11.17bnCN¥10.93bnCN¥10.27bnCN¥9.68bn
Shares outstanding1,593m1,546m1,481m1,368m1,271m1,370m1,333m1,405m1,314m1,324m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsCN¥1.34bn−CN¥43.6mCN¥828.8mCN¥2.21bnCN¥5.08bnCN¥5.36bnCN¥6.54bnCN¥93.5mCN¥131.4mCN¥2.34bn
Capital spending−CN¥1.6m−CN¥31.5m−CN¥32.4m−CN¥22.4m−CN¥46.7m−CN¥36.7m−CN¥56.6m−CN¥54.8m−CN¥107.2m−CN¥13.3m
Free cash flowCN¥1.34bn−CN¥75.1mCN¥796.4mCN¥2.19bnCN¥5.03bnCN¥5.33bnCN¥6.48bnCN¥38.7mCN¥24.2mCN¥2.33bn
Dividends paid−CN¥325.7m−CN¥403.3m−CN¥703.7m−CN¥983.5m−CN¥46.4m−CN¥94.1m−CN¥96.2m−CN¥1.59bn−CN¥1.94bn−CN¥1.85bn

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueCN¥347.4mCN¥401.3mCN¥2.82bnCN¥283.4mCN¥388.2mCN¥344.5mCN¥6.48bnCN¥607.2m
Gross profitCN¥53.3mCN¥9.8mCN¥389.2mCN¥241.7m−CN¥177.4mCN¥66.2m−CN¥432.2mCN¥96.3m
Operating incomeCN¥4.8m−CN¥46.5mCN¥163.0m−CN¥219.2m−CN¥349.9m−CN¥13.3m−CN¥2.45bnCN¥19.4m
Net income−CN¥2.20bn−CN¥133.1m−CN¥3.26bn−CN¥209.3m−CN¥561.7m−CN¥96.1m−CN¥2.62bn−CN¥21.6m
Diluted earnings per share-1.38-0.08-2.05-0.13-0.35-0.06-1.69-0.01
Cash from operations———−CN¥465.0mCN¥408.0mCN¥274.0m—CN¥74.0m
Capital spending————−CN¥1.0m—−CN¥4.0m−CN¥13.0m
Free cash flow————CN¥407.0m——CN¥61.0m
Total assetsCN¥19.91bnCN¥21.66bnCN¥22.32bnCN¥27.86bnCN¥28.60bnCN¥28.38bnCN¥28.11bnCN¥35.91bn
Cash and short-term investments———CN¥1.02bnCN¥1.67bnCN¥1.36bnCN¥1.15bnCN¥1.29bn
DebtCN¥1.55bnCN¥1.81bnCN¥2.15bnCN¥2.96bnCN¥3.88bnCN¥3.74bnCN¥3.42bnCN¥4.00bn
Shareholders' equityCN¥3.03bnCN¥5.23bnCN¥5.37bnCN¥8.63bnCN¥8.78bnCN¥9.34bnCN¥9.43bnCN¥12.07bn

Financial ratios

Data as of 22 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin13.6%1.5%24.8%18.2%17.5%20.7%
Operating margin-95.5%-25.3%11.3%6.4%7.4%12.1%
Net margin-107.6%-29.7%1.2%0.7%1.4%4.1%
Return on equity-76.9%-27.6%0.6%0.9%1.5%2.8%
Return on assets-18.5%-9.3%0.2%0.3%0.4%0.6%
Free cash flow yield45.1%-0.4%31.1%87.3%215.7%210.8%
Revenue growth-56.2%59.0%-63.6%20.7%67.2%-21.6%
Earnings growth58.7%-3906.0%-35.0%-38.5%-44.2%-48.7%
Current ratio1.37x1.72x1.50x1.52x1.39x1.35x
Debt to equity0.40x0.36x0.54x0.34x-0.14x0.45x
Equity ratio24.0%33.5%32.8%29.4%23.1%21.1%
Interest coverage-11.68x-6.78x1.88x2.78x3.15x2.42x
R&D as a share of sales0.7%0.4%0.6%0.2%0.4%0.5%
Buybacks as a share of market value-3.0%-4.4%-8.3%-7.6%7.2%-2.8%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-36.7%-12.6%-7.1%
Operating income-62.9%-44.2%-28.2%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin5.2%14.4%16.0%20.8%
Operating margin-17.4%-3.7%0.1%6.8%
Net margin-53.4%-19.7%-11.4%-2.4%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-0.9-1.564.639.522.616.110.45.412.120.7
Price to sales0.90.50.80.30.30.70.70.60.91.1

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 8 Jul 2024.

FY2024FY2023FY2021FY2020FY2019FY2018FY2017FY2016
Paid in the year0.010.0210.0360.0710.0710.1430.1790.179
  • 7-for-5 split · 8 Jul 2024
  • 1.98-for-1 split · 22 May 2007
  • 1-to-1 reverse split · 9 Nov 2005

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.